Gianni Pantuso

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

POLE-mutated endometrial cancer: new perspectives on the horizon?

POLE-mutated endometrial cancer: new perspectives on the horizon?

Journal: Frontiers in oncology
Published: May 22, 2025

An intriguing journey into the hereditary syndromes predisposing to endometrial cancer: more than believed.

An intriguing journey into the hereditary syndromes predisposing to endometrial cancer: more than believed.

Journal: Therapeutic advances in medical oncology
Published: January 28, 2025

Routine histopathological examination in patients undergoing sigmoidectomy for diverticular disease: Are we ready to avoid it?

Routine histopathological examination in patients undergoing sigmoidectomy for diverticular disease: Are we ready to avoid it?

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Published: November 19, 2024

BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?

BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?

Journal: Frontiers in oncology
Published: April 08, 2024

Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.

Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.

Journal: Critical reviews in oncology/hematology
Published: August 30, 2023

Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer.

Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer.

Journal: BMC cancer
Published: January 12, 2023

Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible.

Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible.

Journal: Critical reviews in oncology/hematology
Published: June 21, 2022

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

Journal: Frontiers in oncology
Published: May 17, 2022

Risk factors for bile leakage after liver resection for neoplastic disease.

Risk factors for bile leakage after liver resection for neoplastic disease.

Journal: Updates in surgery
Published: March 31, 2022

MUTYH-associated tumor syndrome: The other face of MAP.

MUTYH-associated tumor syndrome: The other face of MAP.

Journal: Oncogene
Published: February 23, 2022

Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?

Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?

Journal: Critical reviews in oncology/hematology
Published: November 03, 2021

Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).

Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).

Journal: Therapeutic advances in medical oncology
Published: May 02, 2021
Showing 1-12 of 32

Last Updated: 09/26/2026